SUCRALFATE

Search structure
Trade Names:
Synonyms:
Status: Approved (1981)
Entry Type: Unknown
Molecule Category: UNKNOWN
ATC: A02BX02
UNII: XX73205DH5

Structure
InChI Key JTZPPHUZZDKEOC-RBQAPOGLSA-A
Smile O=S(=O)(OC[C@H]1O[C@@H](O[C@]2(COS(=O)(=O)O[Al](O)O)O[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]2OS(=O)(=O)O[Al](O)O)[C@H](OS(=O)(=O)O[Al](O)O)[C@@H](OS(=O)(=O)O[Al](O)O)[C@@H]1OS(=O)(=O)O[Al](O)O)O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O.O[Al](O)O
InChI
InChI=1S/C11H20O35S8.16Al.40H2O/c12-47(13,14)36-1-3-4(41-49(18,19)20)5(42-50(21,22)23)6(43-51(24,25)26)9(38-3)39-11(2-37-48(15,16)17)8(45-53(30,31)32)7(44-52(27,28)29)10(40-11)46-54(33,34)35;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/h3-10H,1-2H2,(H,12,13,14)(H,15,16,17)(H,18,19,20)(H,21,22,23)(H,24,25,26)(H,27,28,29)(H,30,31,32)(H,33,34,35);;;;;;;;;;;;;;;;;40*1H2/q;16*+3;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/p-48/t3-,4-,5+,6-,7+,8+,9+,10-,11-;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;;/m1......................................................../s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C11H52Al16O75S8
Molecular Weight 2072.71
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
CROSS-LINKING AGENT Glycoproteins cross-linking agent ISBN DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Eosinophilic Esophagitis 0 D057765 ClinicalTrials

Related Entries

Scaffolds

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Gastrointestinal disorders
20.03
General disorders and administration site conditions
12.88
Injury, poisoning and procedural complications
12.61
Nervous system disorders
8.59
Respiratory, thoracic and mediastinal disorders
6.68
Vascular disorders
4.88
Skin and subcutaneous tissue disorders
4.4
Cardiac disorders
3.66
Investigations
3.55
Psychiatric disorders
3.44
Product issues
3.39
Immune system disorders
3.34
Musculoskeletal and connective tissue disorders
2.6
Metabolism and nutrition disorders
2.49

Cross References

Resources Reference
CAS NUMBER 54182-58-0
ChEMBL CHEMBL2367706
FDA SRS XX73205DH5
Guide to Pharmacology 7055
CAS NUMBER 54182-58-0
ChEMBL CHEMBL3989780
FDA SRS XX73205DH5
Guide to Pharmacology 7055
CONTENTS